相关实验视频

Updated: May 9, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

中皮细胞和免疫细胞在瘤微环境中相互作用

Rong Sheng¹, Yujia Yin¹, Xipeng Wang¹

¹Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.

Trends in molecular medicine

|April 30, 2025

概括

瘤微环境 (TME) 中的间皮细胞 (MC) 可以产生免疫抑制状态,阻碍抗瘤免疫力. 了解MCs的理解

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

中皮细胞 (MCs) 对于通过细胞相互作用保持血清完整性和平衡至关重要.
在瘤微环境 (TME) 内的瘤发生和进展中,MCs和瘤细胞之间的相互作用得到了认可.
新出现的证据表明,MCs可以通过诱导免疫抑制TME来促进瘤的进展.

研究的目的:

审查中皮瘤和转移性癌症的TME内MCs的免疫调节功能.
探索MCs诱导癌症免疫抑制的机制.
评估MC介导免疫抑制对瘤生长和治疗反应的影响.

主要方法:

关于研究癌症免疫学中介质细胞的综合文献综述.
对MCS细胞因子,化学因子和外体分泌的研究分析.
检查TME中MC与免疫细胞和瘤细胞的相互作用.

主要成果:

MCs分泌的因素可以招募和调节免疫抑制细胞,从而导致免疫抑制的TME.
这些分泌的因素可以直接与免疫细胞相互作用,抑制抗瘤免疫反应.
抗癌细胞的免疫抑制作用与中皮质瘤和转移性多叶膜/腹膜癌的进展有关.

结论:

中皮细胞在TME中起着重要的免疫调节作用,经常促进免疫抑制.
了解MC驱动的免疫抑制对于开发有效的癌症疗法来治疗间皮瘤和相关癌症至关重要.
针对MC介导的免疫抑制机制可能提供新的治疗策略.

关键词:

与癌症相关的介质细胞.免疫抑制免疫抑制介质细胞是介质细胞.有针对性的治疗.瘤微环境是一个微环境.

更多相关视频

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...